原发性肝肉瘤7例临床分析  

Clinical analysis of primary hepatosarcoma: a report of 7 cases

作　　者：郑苏文[1] 孙磊[2] 尹国文[3] 王太洪[1] 

机构地区：[1]江苏省肿瘤医院普外科,江苏南京210009 [2]江苏省肿瘤医院放射科 [3]江苏省肿瘤医院介入科

出　　处：《中国肿瘤外科杂志》2011年第6期338-340,共3页Chinese Journal of Surgical Oncology

摘　　要：目的探讨原发性肝肉瘤的临床特点及其诊治。方法回顾性分析经手术病理证实的7例原发性肝肉瘤患者的临床资料。结果 7例患者均接受手术治疗。5例获手术切除肿瘤,其中3例行右半肝切除,2例行右半肝切除加术中无水酒精注射。术后分别生存11、12、15、20、21个月;未能行手术切除肿瘤患者均行病灶活检,其中1例同时行肝动脉结扎,1例行肝动脉置管埋泵化疗,分别生存3个月、11个月。术后病理诊断为上皮样血管内皮瘤3例,平滑肌肉瘤3例,癌肉瘤1例。结论原发性肝肉瘤依靠病理免疫组化确诊。手术治疗可能是提高患者生存期的主要手段。Objective To discuss the clinical characterisics and treatment of primary hepatosarcoma. Methods The clinical data of seven patients with the primary hepatosarcoma were retrospectively analyzed. Results Seven cases underwent surgical treatment and were confirmed pathologically of primary hepatosarcoma. Five cases underwent surgical resection. Three cases received right liver resection, two cases received the right liver resection and ethanol injection technique, and the survival time were 11, 12, 15, 20, 21 months respectively. Two cases did not receive surgica｜ resection and carried out biopsy, in which one case nnderwent hepatic artery ligation and one case underwent hepatic artery catheter buried pumps chemotherapy. The survival time of these two cases was 3, 11 months respectively. All cases were confirmed pathologically of leiomyosarco- mas for three cases, hemangioendothelioma for three causes and carcinosarcoma for one case. Conclusions Primary hepatosarcoma is confirmed pathologically by the immunohistochemical studies. The surgical resection may be the most effective therapy to prolong the survival time.

关 键 词：原发性肝肉瘤 诊断 治疗 免疫组化 半肝切除术 无水酒精注射 

分 类 号：R735.7[医药卫生—肿瘤]